Study on OsseoSpeed™ TX Short Implants in a Chinese Population
An Open, Prospective, Multi-center Study Assessing the OsseoSpeed™ TX Length 6 mm in in the Posterior Maxilla and Mandible. A 3-years Follow-up Study.
1 other identifier
interventional
45
1 country
3
Brief Summary
The purpose of this study is to investigate the clinical efficacy of OsseoSpeed™ TX 6 mm implants in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior mandible and maxilla up to 3 years after loading. The hypothesis is that one stage surgery using 6 mm OsseoSpeed™ TX implant in the posterior region is safe and predictable.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2011
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 2, 2011
CompletedFirst Posted
Study publicly available on registry
May 3, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedResults Posted
Study results publicly available
May 10, 2019
CompletedOctober 8, 2019
October 1, 2019
5.1 years
May 2, 2011
February 11, 2019
October 1, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Marginal Bone Level Alteration
Marginal Bone Level determined from radiographs and expressed as the difference from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant, and expressed in millimeters. Marginal Bone Level change calculated from values obtained at delivery of permanent restoration i.e. loading of implants (baseline) compared to the values obtained at the follow-up visit 12 months after loading. Positive value = bone gain, Negative values = bone loss.
Evaluated from implant installation to 12 months after implant loading
Secondary Outcomes (7)
Marginal Bone Level Alteration After 36 Months
Evaluated from implant loading to 36 months after implant loading.
Implant Survival
Evaluated from implant installation to 36 months after implant loading.
Implant Stability
Evaluated 36 months after implant loading.
Condition of the Periimplant Mucosa (PPD).
Evaluated from implant loading to 36 months after implant loading.
Condition of the Periimplant Mucosa (BoP).
Evaluated from implant loading to 36 months after implant loading.
- +2 more secondary outcomes
Study Arms (1)
OsseoSpeed™ TX implants
EXPERIMENTALOsseoSpeed TX implants; Ø 4.0 mm, length 6 mm.
Interventions
Eligibility Criteria
You may qualify if:
- Provision of informed consent
- Female and male aged 20-75 years at enrolment
- In need for 2-3 implants in either side of the posterior mandible or maxilla (premolar and molar region)
- History of edentulism in the study area of at least four months
- Neighboring tooth/teeth to the planned bridge/crowns must have natural root(s)
- Presence of natural teeth, partial prosthesis and/or implants in the opposite jaw in contact with the planned bridge/crowns
- Deemed by the investigator to be suitable for implants of 6 mm length and to have a bone height of at least 6 mm and a bone width of minimum 6 mm
- Deemed by the investigator as likely to present an initially stable implant situation
You may not qualify if:
- Unlikely to be able to comply with study procedures, as judged by the investigator
- Earlier graft procedures in the study area
- Uncontrolled pathologic processes in the oral cavity
- Known or suspected current malignancy
- History of radiation therapy in the head and neck region
- History of chemotherapy within 5 years prior to surgery
- Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration
- Uncontrolled diabetes mellitus
- Corticosteroids or any other medication that could influence post-operative healing and/or osseointegration
- Smoking more than 10 cigarettes/day
- Present alcohol and/or drug abuse
- Involvement in the planning and conduct of the study (applies to both Astra Tech staff and staff at the study site)
- Previous enrolment in the present study
- Simultaneous participation in another clinical study, or participation in a clinical study during the last 6 months
- Subjects that are unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Department of Periodontology, School of Stomatology, Peking University
Beijing, 100081, China
Department of Implantology, School of Stomatology, Peking University
Beijing, China
Second Dental and Periodontal Center, School of Stomatology, Peking University
Beijing, China
Related Publications (2)
Han J, Zhang X, Tang Z, Zhang L, Shi D, Meng H. A prospective, multicenter study assessing the DENTSPLY Implants, OsseoSpeed() TX, length 6 mm in the posterior maxilla and mandible: a 1-year follow-up study. Clin Oral Implants Res. 2016 Apr;27(4):452-7. doi: 10.1111/clr.12587. Epub 2015 Apr 9.
PMID: 25855871RESULTHan J, Tang Z, Zhang X, Meng H. A prospective, multi-center study assessing early loading with short implants in posterior regions. A 3-year post-loading follow-up study. Clin Implant Dent Relat Res. 2018 Feb;20(1):34-42. doi: 10.1111/cid.12568. Epub 2017 Dec 8.
PMID: 29218810RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Manager Global Clinical Research
- Organization
- Dentsply Sirona Implants, Mölndal, SWEDEN
Study Officials
- PRINCIPAL INVESTIGATOR
Huan Xin Meng, Prof
Department of Periodontology, School of Stomatology, Beijing University
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2011
First Posted
May 3, 2011
Study Start
February 1, 2011
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
October 8, 2019
Results First Posted
May 10, 2019
Record last verified: 2019-10